Miguel Castelo-Branco Selected Research

W 7 (W7)

7/2022

Defining milestones for the study of remyelination using the cuprizone mouse model: How early is early?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel Castelo-Branco Research Topics

Disease

18	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2016
13	Type 2 Diabetes Mellitus (MODY) 03/2024 - 06/2014
12	Autism Spectrum Disorder 04/2024 - 01/2018
8	Autistic Disorder (Autism) 03/2024 - 01/2017
8	Stroke (Strokes) 01/2022 - 01/2014
7	Neuroinflammatory Diseases 03/2023 - 01/2019
7	Parkinson Disease (Parkinson's Disease) 01/2021 - 04/2015
6	Cognitive Dysfunction 01/2024 - 01/2016
5	Neurodevelopmental Disorders 03/2024 - 01/2017
5	Calcinosis 02/2024 - 01/2017
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2024 - 11/2014
4	Hypertension (High Blood Pressure) 04/2024 - 10/2010
4	Obesity 04/2024 - 01/2017
4	Atherosclerotic Plaque (Atheroma) 02/2024 - 01/2017
4	Atrophy 01/2024 - 12/2018
4	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2022 - 10/2016
4	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2022 - 03/2013
3	Neoplasms (Cancer) 04/2024 - 02/2014
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2024 - 12/2015
3	Disease Progression 09/2023 - 02/2004
3	Dementia (Dementias) 01/2019 - 01/2016
3	Motor Disorders 01/2017 - 01/2011
2	Epilepsy (Aura) 04/2024 - 01/2022
2	Atherosclerosis 02/2024 - 11/2023
2	Multiple Sclerosis 01/2024 - 07/2022
2	Schizophrenia (Dementia Praecox) 05/2022 - 01/2020
2	Ganglion Cysts (Ganglion) 01/2021 - 01/2013
2	Pancreatitis 06/2020 - 01/2020
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2020 - 01/2018
2	Optic Nerve Diseases (Optic Neuropathy) 12/2018 - 10/2016
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2018 - 02/2011
2	Glucose Intolerance 01/2018 - 10/2017
2	Amyloid Plaque 01/2018 - 01/2018
2	Glaucoma 07/2015 - 02/2004
2	Cataract (Cataracts) 11/2013 - 01/2013
2	Essential Hypertension 02/2011 - 01/2011
1	Weight Loss (Weight Reduction) 04/2024
1	Inflammation (Inflammations) 01/2024
1	Chronic Disease (Chronic Diseases) 01/2024
1	Hyperphagia (Overeating) 12/2023
1	Feeding and Eating Disorders (Eating Disorder) 12/2023
1	Gestational Weight Gain 11/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2023
1	Mental Disorders (Mental Disorder) 03/2023
1	Asphyxia (Suffocation) 03/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Eye Diseases (Eye Disease) 01/2023
1	Retinoblastoma (Glioblastoma, Retinal) 01/2023

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 09/2023 - 02/2004
20	Retinaldehyde (Retinal)IBA 01/2023 - 03/2008
8	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 12/2022 - 01/2011
7	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2016
7	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2023 - 01/2016
7	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 03/2013
5	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 10/2010
4	Sodium Fluoride (Ossin)FDA Link 02/2024 - 02/2020
3	Neurotransmitter Agents (Neurotransmitter)IBA 04/2024 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 10/2017
3	Glutamic Acid (Glutamate)FDA Link 01/2020 - 01/2018
3	Indicators and Reagents (Reagents)IBA 01/2018 - 02/2014
3	Aminobutyrates (Aminobutyric Acid)IBA 01/2017 - 03/2013
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 04/2024 - 11/2023
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024 - 01/2011
2	Fluorine-18IBA 02/2024 - 01/2022
2	Amyloid beta-PeptidesIBA 01/2023 - 10/2022
2	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2023 - 01/2020
2	FluoridesIBA 08/2020 - 01/2017
2	Ataxin-3IBA 01/2020 - 01/2018
2	polyglutamineIBA 01/2020 - 01/2018
2	LeptinIBA 01/2019 - 10/2017
2	EnzymesIBA 01/2019 - 01/2016
2	ImmunosorbentsIBA 01/2019 - 01/2016
2	N-acetylaspartate (N-acetyl aspartate)IBA 01/2018 - 01/2018
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2018 - 04/2015
2	CalciumIBA 01/2017 - 06/2014
1	AutoreceptorsIBA 04/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2024
1	Rosuvastatin Calcium (Crestor)FDA Link 02/2024
1	PolyphenolsIBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 11/2023
1	Excipients (Suspending Agents)IBA 11/2023
1	diethyl phthalateIBA 11/2023
1	phthalic acid (phthalate)IBA 11/2023
1	CosmeticsIBA 11/2023
1	SolutionsIBA 03/2023
1	Serotonin (5 Hydroxytryptamine)IBA 03/2023

Therapy/Procedure

7	Neurofeedback 04/2024 - 12/2015
7	Brain-Computer Interfaces 12/2022 - 01/2011
6	Therapeutics 12/2023 - 12/2010
5	Transcranial Direct Current Stimulation 03/2024 - 01/2020
5	Neurological Rehabilitation 12/2022 - 01/2014
4	Transcranial Magnetic Stimulation 01/2022 - 01/2018
2	Glycemic Control 01/2024 - 01/2023
1	Bariatric Surgery 04/2024
1	Gastrectomy 04/2024
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 04/2024
1	Immunomodulation 01/2024
1	Induced Hypothermia 03/2023
1	Drug Therapy (Chemotherapy) 01/2023